ArticleDiabetes care2016

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.

Angus G Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.